New data from human trials of a COVID-19 drug show it can speed up recovery time in patients.
Wednesday, the National Institute of Allergy and Infectious Diseases released the data from remdesivir trials, including one with the University of Colorado School of Medicine and UCHealth University of Colorado Hospital.